Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

BACKGROUND: Breast cancers with 1–10% cell staining for estrogen receptor (ER) present particular clinical features. The clinical data of estrogen receptor expression level and treatment effect are limited, particularly regarding chemotherapy benefit. We evaluated the pathologic response to neoadjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hai-long, Huang, Feng-bo, Chen, Qiang, Deng, Yong-chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485958/
https://www.ncbi.nlm.nih.gov/pubmed/37684569
http://dx.doi.org/10.1186/s12885-023-11368-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485958/
https://www.ncbi.nlm.nih.gov/pubmed/37684569
http://dx.doi.org/10.1186/s12885-023-11368-2

Ejemplares similares